#3TR will look at 7 diseases, both in parallel and jointly: systemic lupus erythematosus #SLE, rheumatoid arthritis #RA, multiple sclerosis #MS, ulcerative #colitis, #Crohns disease, #asthma, and #COPD. Keep with us on this exciting journey!

New lay summary out!

A #3TR study investigated whether knowing a patient's serum neurofilament light (sNfL) level, a blood-based marker of nerve fibre damage, influenced doctors' clinical decisions in #MS care.

👉 Discover the findings here: 3tr-imi.eu/publications/l…

Great days in Cagliari for the 3TR consortium meeting! 🇮🇹
A pleasure to exchange ideas, discuss progress in lupus research and contribute to our ongoing work.
Onwards! 🦋
#3TR #Lupus #SLE

🔬 Research needs collaboration. Prf Cervera points to @3TR_IMI as a major European research initiative in autoimmune diseases, bringing academia, patoents & industry together.

Lupus Europe is involved in 3TR, helping bring the patient perspective.

#LupusConvention

Three days to go until our 7th #3TR Progress Meeting!

Looking forward to meeting everyone in person again and advancing our collaborative work to better understand treatment response across seven immune-mediated diseases.

See you in Cagliari, Sardinia! 🇮🇹👋

🔎 Discover our first lay summary!

A #3TR study used AI to analyse gene activity in blood samples and identify potential #biomarkers that could help predict response to the #RA medicine adalimumab.

👉 Discover more in the plain-language summary: 3tr-imi.eu/publications/l…

💚Today is Chronic Disease Day!
At CNAG, we're raising awareness of @3TR_IMI, an EU-funded project aiming to study 7 chronic immune-mediated diseases to understand how they are treated: not by their symptoms, but by their shared biology

#ChronicDisease #PreventiveHealth

Two days ago, the #3TR-SLE Steering Group came together in Stockholm for a productive workshop at @karolinskainst.

Thank you to all colleagues for the insightful discussions, collaboration and continued commitment to advancing #SLE research. 🧬🤝

💡 New interview with Ana Brescia Zapata from @genyo_pts!

Within #3TR, Ana works across the SLE and MS research teams, using bioinformatics to identify molecular pathways linked to treatment response.

Read the full interview: 3tr-imi.eu/news-and-media…

#SLE #MS #PrecisionMedicine

Today on #WorldMSDay, we stand with the global MS community. 🧡🔬

Through biomarker research, #3TR aims to advance our understanding of Multiple Sclerosis and other conditions, helping improve outcomes for patients.

#PrecisionMedicine #MS

What happens when research crosses disease borders?

3TR unites patients, clinicians, academia & industry to uncover shared mechanisms behind immune-mediated diseases, bringing us closer to truly personalised medicine.

🎥Get a behind-the-scenes look: youtube.com/watch?v=ZRjr1P…

The first @SIGNATURE_EU_DN newsletter is out! 📩

Building on #3TR, the SIGNATURE EU project advances research in lupus, rheumatoid arthritis and multiple sclerosis for a better understanding of disease mechanisms and treatment response.

Read it here 👇
univ-brest.fr/lbai/sites/lba…

Science works better together. 🔬

On #WorldHealthDay, #3TR celebrates the power of collaboration. By working across academia, pharma and patients we aim to better understand response and non-response to therapy and make personalised treatment a reality.💡

#StandWithScience #IHI

📢 New #3TR story online!

Meet James Perera, rheumatology specialist in training and PhD student at @QMUL, working to identify distinct clinical trajectories in rheumatoid arthritis and support more personalised care.

Read the full interview: 3tr-imi.eu/news-and-media…

Two weeks ago at #SLEuro2026 in Lisbon 📸

Ana Brescia Zapata & María Rivas Torrubia (GENYO) presented their poster on molecular stratification to guide treatment selection in #SLE 🔬

Great to see #3TR partners advancing targeted treatment approaches💡

📣 Meet us at the 15th European Lupus Meeting in Lisbon!

In the coming days, #3TR partners will contribute to the scientific programme organised by the @SLEuroSociety, sharing the latest advances in #lupus research. 🔬

Looking forward to great discussions! 🤝✨

New #3TR story spotlighting young researchers!

Today, we’re featuring Mark Wessels, who supports study logistics & patient visits in 3TR while pursuing his PhD on blood-based biomarkers in #MS at the MS Center @amsterdamumc.

🔎 Read the full interview: 3tr-imi.eu/news-and-media…

Just back from our MS data interpretation group meeting in Madrid. 🤝

We aligned on analysis plans and publications around exciting new consortium data. Stay tuned!💡

#3TR #MS #PrecisionMedicine

On the International Day of Women and Girls in Science, we’re continuing our #3TR stories series spotlighting young researchers. 🔬

Meet Dr. Lina Welz, clinician scientist at @UKSH_KI_HL in Kiel, and learn what motivates her work in #IBD research.

➡️ 3tr-imi.eu/news-and-media…

"3TR Project: Crossing disease borders to reshape European research"
By utilising advanced technologies, the @3TR_IMI aims to transform the understanding and treatment of immune-mediated diseases, with its core principles in precision medicine.

More info: edition.pagesuite-professional.co.uk/html5/reader/p…

Snapshot from our #3TR Joint Steering Committee Meeting at @TakedaPharma in Opfikon, Switzerland📸🤝